XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues [1],[2] $ 88,906 $ 88,479 $ 264,004 $ 261,111
Cost of revenues [1],[2],[3],[4] 52,783 52,005 157,629 154,025
Convertible redeemable preferred stock dividends [1],[2] (4,971) (4,578) (13,904) (13,062)
Total stock-based compensation expense (benefit) 377 (122) 2,863 2,267
Cost of revenues        
Total stock-based compensation expense (benefit) 54 (281) 615 118
Selling and marketing        
Total stock-based compensation expense (benefit) 17 (208) 524 71
Research and development        
Total stock-based compensation expense (benefit) 31 (193) 367 92
General and administrative        
Total stock-based compensation expense (benefit) 275 560 1,357 1,986
Related Party        
Revenues 2,523 2,597 7,412 7,512
Convertible redeemable preferred stock dividends (4,971) (4,578) (13,904) (13,062)
Related Party | Cost of revenues        
Cost of revenues $ 5,679 $ 7,364 $ 16,880 $ 22,964
[1]
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Revenues$2,523 $2,597 $7,412 $7,512 
Cost of revenues5,679 7,364 16,880 22,964 
Convertible redeemable preferred stock dividends(4,971)(4,578)(13,904)(13,062)
[2]
(1) Transactions with related parties are included in the line items above as follows. Refer to Footnote 9, Related Party Transactions.
[3]
(3) Stock-based compensation expense (benefit) is included in the line items above as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Cost of revenues$54 $(281)$615 $118 
Selling and marketing17 (208)524 71 
Research and development31 (193)367 92 
General and administrative275 560 1,357 1,986 
Total stock-based compensation expense (benefit)$377 $(122)$2,863 $2,267 
[4]
(2) Excludes amortization of intangible assets, which is presented as a separate line item.